RSS Feed
Tags
adaptive trials advertising advisory committees best practices biologics biosimilar biotech BLA cancer Cato BioVentures Cato Research CBER CDER CDRH clinical trials CMC conference DDMAC DIA drug development eCTD efficacy FDA GlobalSubmit guest post guidance IND inspections medical devices NDA NIH nonclinical research oncology outsourcing personalized medicine postmarketing protocol safety slides Social Media statistical analysis transparency venture capital warning letters webinarCategories
Archives
Links
Follow us on Twitter!
- Featured yesterday at Fierce Biotech IT - Cato lists five keys to success in adaptive trials http://bit.ly/aHry0A about 17 hours ago from TweetDeck
- RT @reuters: "Outgunned FDA tries to get tough with drug ads" http://bit.ly/btorHn 08:45:47 PM September 07, 2010 from web
- @MicroConstants Thanks for retweeting! 07:27:43 PM September 07, 2010 from TweetDeckin reply to MicroConstants
- New blog post: August 2010 FDA Guidances - http://ask-cato.com/mg 02:50:26 PM September 07, 2010 from WordTwit Plugin
Tag Archives: nonclinical research
July 2010 FDA Guidances
Image via Wikipedia Each month, Cato Research Regulatory Scientist Cathy Anderson compiles a list of the notable guidance documents released by the FDA. Here’s a summary of the guidances released in July 2010 (links go directly to PDF documents). Special … Continue reading
Posted in FDA
Tagged cardiovascular, FDA, guidance, ICH, IND, medical devices, nonclinical research, transdermal
1 Comment
Webinar Slides – Nonclinical Drug Development
Yesterday, Cato Research hosted a webinar titled, “Nonclinical Drug Development – A Successful Path Forward.” Senior Toxicologist Sharon Daily, Ph.D. gave a very informative presentation that was followed by some great questions from the audience. As promised, the slides from … Continue reading
Give Your Scientists an Edge – Partner with a CRO!
Image via Wikipedia This is a guest post by Kathy Grako, Ph.D. Kathy is a Clinical Scientist in Cato Research‘s San Diego, CA office. In the fast paced R&D world, every biotech is looking for an edge to keep them … Continue reading
Posted in Guest Posts, Regulatory Strategy, Venture Capital
Tagged biotech, clinical trials, drug development, nonclinical research, outsourcing, venture capital
Comments Off
Nonclinical Program Considerations for a Pre-IND Meeting
This is a guest post by Tariq Allana, Ph.D. Tariq is a Clinical Strategy Scientist at Cato Research and the Associate Director, Business Development. Developing a well–thought-out nonclinical program is an evolving process. The number and types of animal studies … Continue reading
Cato at the SOT 2010 Annual Meeting
The Society of Toxicology (SOT) will hold its 49th Annual Meeting from March 7-11, 2010 in Salt Lake City, UT. The SOT Annual Meeting is the largest toxicology meeting and exhibition in the world, attracting over 6,000 scientists from industry, … Continue reading
Posted in Conferences and Meetings
Tagged nonclinical research, salt lake city, SOT, toxicology
Comments Off
